Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$19K Sell
1,183
-48,172
-98% -$1.15M ﹤0.01% 187
2019
Q4
$1.35M Sell
49,355
-31,123
-39% -$832K 0.04% 661
2019
Q3
$2.37M Sell
80,478
-37,379
-32% -$1.11M 0.06% 450
2019
Q2
$3.38M Buy
117,857
+102,205
+653% +$3.44M 0.07% 403
2019
Q1
$657K Buy
15,652
+5,717
+58% +$206K 0.01% 1109
2018
Q4
$309K Sell
9,935
-15,142
-60% -$563K 0.01% 1386
2018
Q3
$1.09M Buy
25,077
+22,365
+825% +$634K 0.02% 969
2018
Q2
$45K Buy
+2,712
New +$57.2K ﹤0.01% 1658
2018
Q1
Sell
-8,166
Closed -$104K 1572
2017
Q4
$104K Buy
+8,166
New +$155K ﹤0.01% 1518

Other funds holding AFMD

Oxford Asset Management's AFMD Position: Q1 2020 in Review

Oxford Asset Management reduced its Affimed (AFMD) stake by 98% in Q1 2020, selling an estimated $1.15M and leaving 1,183 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #187.

Oxford Asset Management first reported a position in AFMD in Q4 2017 and has held it in 9 quarters since. The position peaked at $3.38M in Q2 2019. 93 funds tracked by Wall St. Rank hold AFMD as of Q1 2020.

  • Oxford Asset Management held 1,183 shares of Affimed worth $19K as of Q1 2020.
  • Oxford Asset Management sold 48,172 Affimed shares in Q1 2020, an estimated $1.15M.
  • Affimed made up ﹤0.01% of Oxford Asset Management's portfolio in Q1 2020, its #187 holding.
  • Oxford Asset Management first reported a position in Affimed in Q4 2017 and has held it in 9 quarters since.
  • Oxford Asset Management's Affimed position peaked at $3.38M in Q2 2019.
  • 93 funds tracked by Wall St. Rank held Affimed as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.